Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil dosing for recovery after remimazolam anesthesia in elderly ERCP patients
ChiCTR2400086316Phase 4Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jun 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of flumazenil in postoperative sedation (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: open eyes time and Postoperative Quality of Recovery Scale (PQRS) score. Started Jun 2024; status: completed.
02
Drugs
flumazenil
03
Conditions
postoperative sedation
Beyond the preview
Go deeper on ChiCTR2400086316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086316.